Professor Sir Munir Pirmohamed MB ChB (Hons), MRCP, PhD, FRCP, FRCP(E), FBPharmacolS
Professor (Clin,Hcc) Pharmacology & Therapeutics
- +44 (0)151 794 5549
- Work email Munirp@liverpool.ac.uk
- Personal Websitehttp://liv.ac.uk/pharmacogenetics/
Professional Activities
Conference Roles
- Designer Medicines, by Invitation (ASE, 2008)
- Pharmacogenetic prediction of adverse drug reactions, by Invitation (ASCEPT, 2007)
- Adverse drug reactions: from patients to genes, by Invitation (ASCEPT, 2007)
- Pharmacogenomics and pharmacovigilance, by Invitation (Indo-French Collaboration, 2007)
- Pharmacogenetics of adverse drug reactions and role in pharmacovigilance, by Invitation (University of Canberrra, 2007)
- Pharmacogenetics: current situation, challenges and opportunities, by Invitation (University of Bendigo, Australia, 2007)
- Pharmacogenomics and the cardiovascular system: challenges and opportunities, by Invitation (Baker Heart Research Institute, Melbourne, Australia, 2007)
- Idiosyncratic adverse drug reactions: from molecule to man, by Invitation (St Vincent's Hospital, Sydney, Australia, 2007)
- Adverse drug reactions, by Invitation (Therapeutics and Goods Administration. Canberra, Australia, 2007)
- Pharmacogenetics: current status, future challenges, by Invitation (ESPR, 2007)
- Pharmacogenetics of drug hypersensitivity, by Invitation (ISOP, 2007)
- Cytochrome P450 testing: A case study, by Invitation (Academy of Medical Sciences, 2007)
- Safety Monitoring, by Invitation (MHRA, 2007)
- Personalising risk for the patient over the next 20 year., by Invitation (BrAPP, FPS, RSM, 2007)
- Anti-epileptic drugs: past, present and future, by Invitation (ER-UK, 2007)
- Will pharmacogenetics ever have a role in pharmacovigilance? , by Invitation (EACPT, 2007)
- Adverse drug reactions: which one’s can we predict? The clinical perspective, by Invitation (Gordon Research Conferences, 2007)
- Pharmacogenetics: present situation and perspectives on clinical application, by Invitation (ESF, 2007)
- The skin, drugs and T-cells: a significant, but sometimes uncomfortable, threesome, by Invitation (Toronto Western Hospital, 2007)
- Pharmacogenetics in drug hypersensitivity, by Invitation (Swiss Society of Allergy and Immunology, and the Swiss Society of Dermatology and Venereology, 2007)
- Pharmacogenetics of adverse drug reactions, by Invitation (Conference Organisers, 2007)
- Pharmacogenetics in Gastroenterology, by Invitation (University of Nottingham, 2007)
- Pharmacogenetics: hype or hope? , by Invitation (European College of Neuro-Psychopharmacology , 2007)
- Pharmacogenetics of adverse drug reactions, by Invitation (Royal Society of Medicine, 2007)
- Yellow cards – moving forwards, by Invitation (MHRA, 2007)
- Hapten-independent T-cell drug reactions: evidence and implications, by Invitation (AAAAI, 2007)
- Pharmacogenetics: a clinical perspective, by Invitation (Epidauros, 2007)
- Recent initiatives in pharmacogenetics in the UK, by Invitation (NIH Pharmacogenetics Research Network, 2006)
- The future of pharmacogenetics and its impact on healthcare systems, by Invitation (MHRA, 2006)
- Pharmacogenetics in practice: the challenge of translation, by Invitation (Generation Scotland, 2006)
- Genetic prediction of adverse drug reactions, by Invitation (ISOP, 2006)
- Pharmacogenetics in clinical practice: the problem of translation, by Invitation (Dutch Royal Pharmaceutical Society, 2006)
- Adverse drug reactions: incidence and role of pharmacists, by Invitation (UK Medicine Information Pharmacists, 2006)
- Pharmacogenetics and adverse drug reactions, by Invitation (RPSGB, 2006)
- Personalised pills. From Pythagoras to the present, by Invitation (British Pharmacological Society, 2006)
- Pharmacogenetics: theoretical background and practical problems, by Invitation (IUPHAR, 2006)
- Will pharmacogenetics ever have a role in pharmacovigilanc? , by Invitation (Conference Organisers, 2006)
- Why are some patients harmed by a medicine while others are not? , by Invitation (British Society for Ecological Medicine, 2006)
- Individual basis of susceptibility to adverse drug reactions, by Invitation (ISSX, 2006)
- Genetic basis of adverse drug reactions, by Invitation (DG Research, 2006)
- Drug safety: scale of the problems and developing solutions, by Invitation (Southport District General Hospital, 2006)
- Pharmacogenomics of herbal medicines, by Invitation (Conference Organisers, 2006)
- Recent advances in pharmaco- and immunogenetics, by Invitation (Conference Organisers, 2006)
- This is the drug for you, Madam, by Invitation (Epilepsy Research Foundation, 2006)
- Optimal genotyping strategies in pharmacogenomics, by Invitation (Genomes to Systems Conference. Manchester, 2006)
- Mechanisms of drug-induced hepatotoxicity, by Invitation (British Co-Infection Association, 2006)
- Pharmacogenetics of HIV therapy, by Invitation (London IDEAS Genetics Knowledge Park, 2005)
- Pharmacogenetics, by Invitation (Cambridge Genetics Knowledge Park, 2005)
- What are personalised medicines and what will they mean to the dynamics of healthcare? , by Invitation (Tech-Link Ireland, 2005)
- Pharmacogenetics of adverse drug reactions, by Invitation (PK-UK, 2005)
- Drug safety: a continuing public health problem, by Invitation (Royal College of Physiciana, 2005)
- Epilepsy pharmacogenetics, by Invitation (Banbury Centre, Cold Spring Harbor Laboratory, 2005)
- Drug Safety: Defining the Problems and Developing Solutions, by Invitation (University of Toronto, 2005)
- Immune-mediated drug hypersensitivity: an overview, by Invitation (British Society of Allergy and Clinical Immunology , 2005)
- Drug-induced liver injury: working towards better diagnostic and preventive strategies, by Invitation (Gordon Research Conferences, 2005)
- Genetic aspects of drug-induced hypersensitivity reactions, by Invitation (Gordon Research Conferences, 2005)
- Pharmacogenetics of antiepileptic drugs, by Invitation (Royal Liverpool Childrens Hospital, 2005)
- Drug interactions: new mechanisms, new issues, by Invitation (Royal College of Physicians of Edinburgh, 2005)
- Pharmacogenomics: current status, by Invitation (University of Edinburgh, 2005)
- Pharmacogenetics and antiviral drugs, by Invitation (IFCC-FESCC , 2005)
- Pharmacogenetics: current status and future potential, by Invitation (MerseyBio, 2005)
- Pharmacogenetics: Study Designs, Potential Problems and Possible Solutions, by Invitation (Drug Safety Research Unit, 2005)
- Pharmacogenetics and Clinical Practice: Challenges and Prospects, by Invitation (GlaxoSmithKline Pharmaceuticals, 2005)
- New Insights into the Pathogenesis of Allergic Drug Reactions, by Invitation (American Academy of Allergy, Asthma and Immunology, 2005)
- Cardiovascular pharmacogenetics, by Invitation (London Hypertension Society, 2005)
- Principles of pharmacogenetics, problems and possible solutions, by Invitation (British Society of Gastroenterology, 2005)
- Pharmacovigilance in the future, by Invitation (EMEA, 2005)
- Immune Pathogenesis of Drug-Induced Liver Disease, by Invitation (Swiss Society for Allergology and Immunology, 2005)
Editorships
- Frontiers in Pharmacogenetics (Invited Associate Editor)
- Pharmacogenomics (Editorial Board Member, 2008 - present)
- Pharmaceutical Research (Editorial Board Member, 2007 - present)
- Pharmacogenetics & Genomics (Editorial Board Member, 2007 - present)
- Current Drug Safety (Editorial Board Member, 2005 - present)
- Therapeutics and Clinical Risk Management (Editorial Board Member, 2004 - present)
- Expert Opinion on Pharmacotherapy (Editorial Board Member, 2004 - present)
- Drug Safety (Editorial Board Member, 2004 - present)
- Expert Opinion on Drug Safety (Editorial Board Member, 2002 - present)
- Postgraduate Medical Journal (Editorial Board, 1999 - 2006)
Examination Roles
- University of Cambridge, UK, PhD (2007)
- University College London, UK, PhD (2006)
- University of Newcastle upon Tyne, PhD (2006)
- Cardiff University (Wales), MD (PGT, 2006)
- University of St Andrews, MBBS (UG, 2006)
- Murdoch University Australia, PhD (2006)
- University of St Andrews, MBBS (UG, 2005)
- University of Newcastle upon Tyne, PhD (2005)
- University of Dundee, MSc (PGT, 2004)
Professional Body Memberships
- British Medical Association (Member)
- Medical Protection Society (Member)
- British Pharmacological Society (Fellow)
- Liverpool Medical Institution (Member)
- Fellowship of Postgraduate Medicine (Fellow)
- Medical Research Society (Member)
- Medical Council on Alcohol (Regional Advisor)
- Association of Physicians (Member)
- Royal College of Physicians (Fellow, 2000 - present)
- Royal College of Physicians (Edinburgh) (Fellow, 1999 - present)
- Royal College of Physicians (Member, 1988 - present)